Pharma Giants Combine Forces to Fight New M&A Rules
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.
Meet the anti-antitrust coalition.
With a looming overhaul of US merger-and-acquisition law set to reshape the economics of the M pharmaceutical industry, 31 of its biggest players -- including Merck, Amgen, Abbvie, and Gilead -- formed an alliance to fight the reforms. Their chief enemy? Khaaaaaaaaaaan!
Source Fool.com
Amgen Inc. Stock
€307.20
-0.440%
With 25 Buy predictions and not a single Sell prediction Amgen Inc. is an absolute favorite of our community.
However, we have a potential of -1.04% for Amgen Inc. as the target price of 304 € is below the current price of 307.2 €.
